You are here: Industry Insights > levodopa

News List

Treatment for Parkinson's OFF Periods: Istradefylline David Orchard-Webb
July 01, 2024
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain.One promising treatment for managing these off periods is Istradefylline, an adenosine A2A receptor antagonist.
Levodopa Market Size and Major Suppliers, Bulk Source of Levodopa API Powder PharmaSources
June 22, 2021
Levodopa is a precursor of dopamine that is commonly used in the treatment and management of Parkinson’s disease because of its ability to cross the blood brain barrier.
Levodopa may improve vision in patients with macular degeneration Elsevier
September 24, 2020
Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision.
Zydus Cadila gets tentative US FDA approval for Carbidopa and Levodopa extended-release capsules expresspharma
August 03, 2020
This medication is used to treat the symptoms of Parkinson’s disease or Parkinson-like conditions.
Nourianz Approved to Treat 'Off' Episodes in Parkinson Disease drugs
August 29, 2019
Nourianz (istradefylline) tablets have been approved as an add-on treatment to levodopa/carbidopa for adults with Parkinson disease experiencing "off" episodes...
Good News, Bad News on Levodopa for Parkinson's Disease drugs
January 24, 2019
The most potent drug available for Parkinson's disease, levodopa, treats symptoms of the disease but does nothing to either ease or increase its still-mysterious underlying causes, a new clinical trial has concluded.....